and IA-05 EUP trials. Unit from published sources (, ). There is no reason to believe that Children the experience the improvement same HRQoL in HRQoL improvement would be Children from different omalizumab between therapy as patients under adults and and over 12 adolescents. years of age. The increase in the
and IA-05 EUP trials. Unit from published sources (, ). Children Children experience the same HRQoL improvement from omalizumab therapy as adults and adolescents. There is no reason to believe that the improvement in HRQoL would be different between patients under and over 12 years of age. The increase in the